Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Camp Lejeune Cases
  • Drug Injury
  • Free Case Evaluation
  • About Us

May 2018 Gadolinium Deposition Disease Update Issued By Health Canada

July 23, 2018 By Law Offices of Thomas J. Lamb, P.A.

In May 2018 Health Canada announced the results of its second safety review of Magnevist, MultiHance, Omniscan, and Optimark, as well as other gadolinium contrast injections for MRIs, CT scans, and other radiology procedures. In May 2018 Health Canada issued this document, “Summary Safety Review – Gadolinium based contrast agents – Assessing the … [Read more...]

Filed Under: Unsafe Drugs Tagged With: gad, Gadolinium deposition disease, gadolinium retention, Gadolinium storage condition, gadolinium-based contrast agents, gadolinium-containing contrast

MRI Contrast Agents: Gadolinium Retention Warnings Added To Drug Label

May 21, 2018 By Law Offices of Thomas J. Lamb, P.A.

The gadolinium contrast agents safety warnings announced by the FDA in December 2017 started to be seen on new drug labels approved in the spring of 2018. It is important to understand that symptoms of gadolinium-related medical conditions can first appear anywhere from just a few hours until several weeks after the MRI or MRA procedure when a … [Read more...]

Filed Under: Unsafe Drugs Tagged With: gad, Gadolinium deposition disease, gadolinium retention, Gadolinium storage condition, gadolinium-based contrast agents, gadolinium-containing contrast

Gadolinium Deposition Disease Explained: How It Is Diagnosed, And More

May 16, 2018 By Law Offices of Thomas J. Lamb, P.A.

A person who received an injection of a gadolinium-based contrast agent (GBCA) may develop some medical conditions following their MRI or MRA procedure which could be symptoms of gadolinium deposition disease. These various gadolinium-related symptoms include: Persistent headache; “Brain fog”; Skin that appears spongy or rubbery, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: gadolinium, Gadolinium deposition disease, gadolinium retention, Gadolinium storage condition, gadolinium-based contrast agents, gadolinium-containing contrast

FDA And MHRA Actions For Gadolinium-Containing Contrast Agents Differ

December 21, 2017 By Law Offices of Thomas J. Lamb, P.A.

There is a difference between the United States FDA and the United Kingdom MHRA in terms of the regulatory actions being taken with respect gadolinium-based contrast agents (GBCAs). The drug safety issue is that low levels of gadolinium can be retained in the brain and other tissuesfor months to years after the administration of these drugs for … [Read more...]

Filed Under: Unsafe Drugs Tagged With: gadolinium retention, gadolinium-based contrast agents, gadolinium-containing contrast, Magnevist, Omniscan, OptiMARK

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • PFAS Firefighter Gear Lawsuits
  • Camp Lejeune Cases
  • GenX Water Cancer Cases
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Philips Breathing Devices Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.